KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Liabilities and Shareholders Equity (2018 - 2025)

Twist Bioscience (TWST) has disclosed Liabilities and Shareholders Equity for 6 consecutive years, with $853.9 million as the latest value for Q1 2023.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 16.42% to $853.9 million in Q1 2023 year-over-year; TTM through Sep 2023 was $853.9 million, a 69.16% decrease, with the full-year FY2022 number at $961.4 million, up 36.93% from a year prior.
  • Liabilities and Shareholders Equity was $853.9 million for Q1 2023 at Twist Bioscience, down from $961.4 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $1.0 billion in Q1 2022 to a low of $140.2 million in Q1 2019.
  • A 5-year average of $552.1 million and a median of $677.3 million in 2021 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: skyrocketed 131.06% in 2020, then dropped 16.42% in 2023.
  • Twist Bioscience's Liabilities and Shareholders Equity stood at $192.3 million in 2019, then soared by 107.45% to $398.9 million in 2020, then skyrocketed by 97.09% to $786.2 million in 2021, then rose by 22.29% to $961.4 million in 2022, then dropped by 11.18% to $853.9 million in 2023.
  • Per Business Quant, the three most recent readings for TWST's Liabilities and Shareholders Equity are $853.9 million (Q1 2023), $961.4 million (Q3 2022), and $1.0 billion (Q1 2022).